Rendering

Component: (Network and Table)
Network
2413407 - Disclosure - Stock-based Compensation - Schedule of Restricted Stock Activity (Details)
(http://www.aeriepharma.com/role/StockBasedCompensationScheduleOfRestrictedStockActivityDetails)
TableSchedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001337553 (http://www.sec.gov/CIK)
Award Type [Axis]Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]Period [Axis]
2016-01-01 - 2016-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
 
NUMBER OF SHARES
 
RSAs outstanding, beginning (in shares)
119,993  
Granted, number of shares (in shares)
112,655  
Vested (in shares)
(62,905) 
Cancelled (in shares)
(5,549) 
RSAs outstanding, ending (in shares)
164,194  
 
WEIGHTED AVERAGE FAIR VALUE PER SHARE
 
RSAs outstanding, weighted average exercise price, beginning (in dollars per share)
20.31  
Granted, weighted average exercise price (in dollars per share)
15.98  
Vested, Weighted average exercise price (in dollars per share)
13.71  
Cancelled, weighted average exercise price (in dollars per share)
20.04  
RSAs outstanding, weighted average exercise price, ending (in dollars per share)
19.87